Literature DB >> 15374729

Intermittent low-dose finasteride is as effective as daily administration for the treatment of hirsute women.

Massimo Tartagni1, Matteo Maria Schonauer, Ettore Cicinelli, Filomena Petruzzelli, Giovanni De Pergola, Maria Antonietta De Salvia, Giuseppe Loverro.   

Abstract

In a prospective randomized study 38 women with idiopathic hirsutism or polycystic ovary syndrome (PCOS) received 2.5 mg of finasteride every day or every 3 days. Intermittent low-dose administration of finasteride was as effective as continuous administration in reducing hirsutism score and was accompanied by a lower incidence of side effects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15374729     DOI: 10.1016/j.fertnstert.2004.02.118

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  3 in total

Review 1.  Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies.

Authors:  Raquel N Rozner; Azael Freites-Martinez; Jerry Shapiro; Eliza B Geer; Shari Goldfarb; Mario E Lacouture
Journal:  Breast Cancer Res Treat       Date:  2018-11-22       Impact factor: 4.872

2.  Preparation and clinical evaluation of Finastride gel in the treatment of idiopathic Hirsutism.

Authors:  Reza Tahvilian; Ali Ebrahimi; Omid Beiki; Hoshang Nemati; Sahar Masoud
Journal:  J Drug Assess       Date:  2015-06-18

Review 3.  Spironolactone Versus Oral Contraceptive Pills in the Treatment of Adolescent Polycystic Ovarian Syndrome: A Systematic Review.

Authors:  Shriya Rajashekar; Suganya Giri Ravindran; Meghana Kakarla; Musa Ausaja Gambo; Mustafa Yousri Salama; Nathalie Haidar Ismail; Pardis Tavalla; Pulkita Uppal; Shaza A Mohammed; Pousette Hamid
Journal:  Cureus       Date:  2022-05-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.